Open an account

Enfusion

ENFN · NYSE

Price unavailable right now.

No price history for this range.

About ENFN

Enfusion, Inc. engages in the development of cloud-native multi-tenant software for alternative and institutional investment managers. The company is headquartered in Chicago, Illinois and currently employs 1,143 full-time employees. The Company, through its software, analytics, and middle/back-office managed services, creates enterprise-wide cultures of real-time, data-driven intelligence and collaboration. Its cloud-native, purposefully designed, end-to-end solution gives clients the ability to access and analyze investment information in real time, perform complex calculations quickly and interact with markets electronically, adding up to making better informed investment decisions and actions. Its solutions include a portfolio management system (PMS), an order and execution management system (OEMS), an accounting/general ledger system, an Enfusion analytics system and offer technology-powered, managed services. Its solution is utilized by a variety of users, including portfolio managers, traders, compliance officers, operational support staff and executive management.

Employees
1,143
Headquarters
Chicago, Illinois
Listed
Oct 21, 2021
Sector
Information Technology
Industry
Software
Website
enfusion.com

ENFN key statistics

This section is temporarily unavailable. Refresh to try again.

ENFN earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 2 of the last 8 quarters, by 31.6% on average.

  1. Q1 FY23: reported $0.02 per share against an estimate of $0.028
  2. Q2 FY23: reported $0.04 per share against an estimate of $0.0425
  3. Q3 FY23: reported $0.04 per share against an estimate of $0.0466
  4. Q4 FY23: reported $0.04 per share against an estimate of $0.0536
  5. Q1 FY24: reported $0.06 per share against an estimate of $0.037
  6. Q2 FY24: reported $0.05 per share against an estimate of $0.0574
  7. Q3 FY24: reported $0.05 per share against an estimate of $0.0495
  8. Q4 FY24: reported $0.03 per share against an estimate of $0.0638

ENFN news

  • Press releasePRNewswire

    OPENLANE Names Brad Herring Chief Financial Officer

  • Press releaseBusiness Wire

    Clearwater Analytics Finalizes Acquisition of Enfusion

  • Press releaseBusiness Wire

    Clearwater Analytics and Enfusion Announce Preliminary Results of Election by Enfusion Shareholders Regarding Form of Merger Consideration

  • Press releasePRNewswire

    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, TGI, BECN on Behalf of Shareholders

  • Press releaseBusiness Wire

    Clearwater Analytics and Enfusion Announce Election Deadline for Enfusion Shareholders to Elect Form of Merger Consideration

  • Press releaseBusiness Wire

    ENFUSION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enfusion, Inc. - ENFN

  • Press releaseBusiness Wire

    Enfusion Announces Fourth Quarter and Full Year 2024 Results

  • Press releaseBusiness Wire

    Clearwater Analytics and Enfusion Announce Expiration of Hart-Scott-Rodino Act Waiting Period For Proposed Acquisition of Enfusion

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.